Dear all,
I’m interested in further developing some specific use cases where open data (i.e. available under CC0 or equivalent terms) in journal publications would be useful or lack of open data has been problematic – to individual scientists/research groups, and perhaps even the original data publishers. I’m aware of reasonable evidence of societal/economic benefits for open data (e.g. within : http://ie-repository.jisc.ac.uk/279/2/JISC_data_sharing_finalreport.pdf; http://www.jisc.ac.uk/media/documents/publications/keepingresearchdatasafe0408.pdf) but more evidence (aside from more citations, in microarray research), or anecdotes/cases studies in its absence, of benefits to individuals/groups would be good.
E.g. “I am scientist doing X kind of experiment and being able to reuse or harvest all types of Y data from Z journal (or publisher) would be excellent because…”
And ideally…
“here’s why the current model prohibits or makes this difficult; or here’s an example of where such an approach has been beneficial previously….
I’d like to include some of these use cases as part of a white paper, currently well under way, on implementation of a variable license agreement for open access publications enabling CC0 for data (as agreed at http://blogs.openaccesscentral.com/blogs/bmcblog/entry/report_from_the_publishing_open).
If anyone has any suggestions they would be much appreciated – and of course acknowledged.
Best regards,
Iain
Iain Hrynaszkiewicz
Journal Publisher
BioMed Central
236 Gray's Inn Road
London, WC1X 8HB
T: +44 (0)20 3192 2175
F: +44 (0)20 3192 2011
M: +44 (0)782 594 0538
W: www.biomedcentral.com
Skype: iainh_z